BACKGROUND: Multiple studies have shown that cerebral tissue oxygen saturation (Sct(O(2))) is decreased after phenylephrine treatment. We hypothesized that the negative impact of phenylephrine administration on Sct(O(2)) is affected by arterial blood carbon dioxide partial pressure (Pa(CO(2))) because CO(2) is a powerful modulator of cerebrovascular tone. METHODS: In 14 anaesthetized healthy patients, i.v. phenylephrine bolus was administered to increase the mean arterial pressure ~20-30% during hypocapnia, normocapnia, and hypercapnia. Sct(O(2)) and cerebral blood volume (CBV) were measured using frequency domain near-infrared spectroscopy, a quantitative technology. Data collection occurred before and after each treatment. RESULTS: Phenylephrine caused a significant decrease in Sct(O(2)) during hypocapnia [ΔSct(O(2)) =-3.4 (1.5)%, P<0.001], normocapnia [ΔSct(O(2)) =-2.4 (1.5)%, P<0.001], and hypercapnia [ΔSct(O(2)) =-1.4 (1.5)%, P<0.01]. Decreases in Sct(O(2)) were significantly different between hypocapnia, normocapnia, and hypercapnia (P<0.001). Phenylephrine also caused a significant decrease in CBV during hypocapnia (P<0.01), but not during normocapnia or hypercapnia. CONCLUSION: The negative impact of phenylephrine treatment on Sct(O(2)) and CBV is intensified during hypocapnia while blunted during hypercapnia.
BACKGROUND: Multiple studies have shown that cerebral tissue oxygen saturation (Sct(O(2))) is decreased after phenylephrine treatment. We hypothesized that the negative impact of phenylephrine administration on Sct(O(2)) is affected by arterial blood carbon dioxide partial pressure (Pa(CO(2))) because CO(2) is a powerful modulator of cerebrovascular tone. METHODS: In 14 anaesthetized healthy patients, i.v. phenylephrine bolus was administered to increase the mean arterial pressure ~20-30% during hypocapnia, normocapnia, and hypercapnia. Sct(O(2)) and cerebral blood volume (CBV) were measured using frequency domain near-infrared spectroscopy, a quantitative technology. Data collection occurred before and after each treatment. RESULTS:Phenylephrine caused a significant decrease in Sct(O(2)) during hypocapnia [ΔSct(O(2)) =-3.4 (1.5)%, P<0.001], normocapnia [ΔSct(O(2)) =-2.4 (1.5)%, P<0.001], and hypercapnia [ΔSct(O(2)) =-1.4 (1.5)%, P<0.01]. Decreases in Sct(O(2)) were significantly different between hypocapnia, normocapnia, and hypercapnia (P<0.001). Phenylephrine also caused a significant decrease in CBV during hypocapnia (P<0.01), but not during normocapnia or hypercapnia. CONCLUSION: The negative impact of phenylephrine treatment on Sct(O(2)) and CBV is intensified during hypocapnia while blunted during hypercapnia.
Authors: Ilias Tachtsidis; Terence S Leung; Caroline Oliver; Julian R Henty; Holly Jones; Martin Smith; David T Delpy; Clare E Elwell Journal: Adv Exp Med Biol Date: 2006 Impact factor: 2.622
Authors: Shigehiko Ogoh; R Matthew Brothers; Quinton Barnes; Wendy L Eubank; Megan N Hawkins; Sushmita Purkayastha; Albert O-Yurvati; Peter B Raven Journal: J Physiol Date: 2005-10-06 Impact factor: 5.182
Authors: Patrice Brassard; Thomas Seifert; Mads Wissenberg; Peter M Jensen; Christian K Hansen; Niels H Secher Journal: J Appl Physiol (1985) Date: 2010-03-11
Authors: Li Lin; Junjie Yao; Ruiying Zhang; Chun-Cheng Chen; Chih-Hsien Huang; Yang Li; Lidai Wang; William Chapman; Jun Zou; Lihong V Wang Journal: J Biophotonics Date: 2016-12-23 Impact factor: 3.207
Authors: B S Alexander; A W Gelb; W W Mantulin; A E Cerussi; B J Tromberg; Z Yu; C Lee; L Meng Journal: Acta Anaesthesiol Scand Date: 2013-01-02 Impact factor: 2.105
Authors: Khalil M Yousef; Elizabeth Crago; Yuefang Chang; Theodore F Lagattuta; Khadejah Mahmoud; Lori Shutter; Jeffrey R Balzer; Michael R Pinsky; Robert M Friedlander; Marilyn Hravnak Journal: J Neurosci Nurs Date: 2018-08 Impact factor: 1.230
Authors: Roy A Stillwell; Vincent J Kitsmiller; Alicia Y Wei; Alyssa Chong; Lyla Senn; Thomas D O'Sullivan Journal: Biomed Opt Express Date: 2021-11-01 Impact factor: 3.732